Bausch Health Companies Reaffirms 2024 Revenues Of $9.3B-$9.55B Versus Consensus Of $9.39B, With Adjusted EBITDA Of $3.20B-$3.35B
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies has reaffirmed its 2024 revenue forecast to be between $9.3 billion and $9.55 billion, aligning with the consensus estimate of $9.39 billion. Additionally, the company expects its adjusted EBITDA for the same period to range from $3.20 billion to $3.35 billion.
May 02, 2024 | 11:16 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bausch Health Companies reaffirms its 2024 revenue and adjusted EBITDA forecasts, indicating strong future performance expectations.
Reaffirming both revenue and EBITDA forecasts suggests Bausch Health is confident in its operational stability and growth prospects. This positive outlook, especially when in line with consensus estimates, is likely to foster investor confidence and could lead to a short-term uptick in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100